Florian Deckert

Florian Deckert

Auto-generated profile, based on publicly available information

Florian Deckert

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in Science Immunology
Verified
Journal Article
Closed access
AFAsma Farhat
Asma Farhat
MRMariem Radhouani
Mariem Radhouani
FDFlorian Deckert
Florian Deckert
SZSophie Zahalka
Sophie Zahalka
LPLisabeth Pimenov
Lisabeth Pimenov
SKSylvia Knapp
Sylvia Knapp
Pulmonary fibrosis is an incurable disease that manifests with advanced age. Yet, how hematopoietic aging influences immune responses and fibrosis progression remains unclear. Using heterochronic bone marrow transplant mouse models, we found that an aged bone marrow exacerbates lung fibrosis irrespective of lung tissue age. Upon lung injury, there was an increased accumulation of monocyte-derived alveolar macrophages (Mo-AMs) driven by cell-intrinsic hematopoietic aging. These Mo-AMs exhibited an enhanced profibrotic profile and stalled maturation into a homeostatic, tissue-resident phenotype. This delay was shaped by cell-extrinsic environmental signals such as reduced pulmonary interleukin-10 (IL-10), perpetuating a profibrotic macrophage state. We identified regulatory T cells (T regs ) as critical providers of IL-10 upon lung injury that promote Mo-AM maturation and attenuate fibrosis progression. Our study highlights the impact of an aging bone marrow on lung immune regulation and identifies T reg -mediated IL-10 signaling as a promising target to mitigate fibrosis and promote tissue repair.

5 June 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
RGRiem Gawish
Riem Gawish
RVRajagopal Varada
Rajagopal Varada
FDFlorian Deckert
Florian Deckert
AHAnastasiya Hladik
Anastasiya Hladik
LSLinda Steinbichl
Linda Steinbichl
CVCornelia Vesely
Cornelia Vesely
Patho-mechanistic origins of ulcerative colitis are still poorly understood. The actin cross-linker filamin A (FLNA) impacts cellular responses through interaction with cytosolic proteins. Posttranscriptional A-to-I editing generates two forms of FLNA: genome-encoded FLNAQ and FLNAR. FLNA is edited in colon fibroblasts, smooth muscle cells, and endothelial cells. We found that the FLNA editing status determines colitis severity. Editing was highest in healthy colons and reduced during murine and human colitis. Mice that exclusively express FLNAR were highly resistant to DSS-induced colitis, whereas fully FLNAQ animals developed severe inflammation. While the genetic induction of FLNA editing influenced transcriptional states of structural cells and microbiome composition, we found that FLNAR exerts protection specifically via myeloid cells, which are physiologically unedited. Introducing fixed FLNAR did not hamper cell migration but reduced macrophage inflammation and rendered neutrophils less prone to NETosis. Thus, loss of FLNA editing correlates with colitis severity, and targeted editing of myeloid cells serves as a novel therapeutic approach in intestinal inflammation.

12 October 2022 in Leukemia
Verified
Journal Article
Closed access
PDF file
NBNadine Bayer
Nadine Bayer
BHBela Hausmann
Bela Hausmann
RPRam Vinay Pandey
Ram Vinay Pandey
FDFlorian Deckert
Florian Deckert
LGLaura-Marie Gail
Laura-Marie Gail
GSGeorg Stary
Georg Stary

14 February 2023 in Leukemia
Verified
Journal Article
Open access
PDF file
NBNadine Bayer
Nadine Bayer
BHBela Hausmann
Bela Hausmann
RPRam Vinay Pandey
Ram Vinay Pandey
FDFlorian Deckert
Florian Deckert
LGLaura-Marie Gail
Laura-Marie Gail
GSGeorg Stary
Georg Stary
In this article the author name Bela Hausmann was incorrectly written as Bela Hausman.